Tim Chambers - Concepedia

Author

Tim Chambers

Also Known As

Carmen Wong, Chambers, T, Chambers, Tim, J Bradfield, Kang, Neal Navani, Ryan Gage, T Chambers, T J Chambers, T. CHAMBERS

197

Publications

15.7K

Citations

H-Index

138

Concepts

All Affiliations

St George's, University of London University of Otago St George's Hospital University of Auckland Michigan State University

About

Tim Chambers is an author at St George's, University of London specializing in medicine, osteoporosis, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	9	9	562
2	Management	3	3	83
3	Arts	2	2	59
4	Education	1	1	90
5	Engineering	1	1	198

Tim Chambers

Publications

14K

Citations

H-Index

Page 1

	Year	Citations
Tracking the Evolution of Non–Small-Cell Lung Cancer Mariam Jamal‐Hanjani, Gareth A. Wilson, Nicholas McGranahan, New England Journal of Medicine	2017	2.3K
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution Christopher Abbosh, Nicolai J. Birkbak, Gareth A. Wilson, Nature	2017	1.8K
Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution Nicholas McGranahan, Rachel Rosenthal, Crispin T. Hiley, Cell	2017	1.3K
Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis Samra Turajlic, Kevin Litchfield, Hang Xu, The Lancet Oncology	2017	912
Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal Samra Turajlic, Hang Xu, Kevin Litchfield, Cell Tumor BiologyMetastatic CcrccUrologyGenitourinary CancerTumor Heterogeneity	2018	835
Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal Samra Turajlic, Hang Xu, Kevin Litchfield, Cell	2018	640
TRANCE Is Necessary and Sufficient for Osteoblast-mediated Activation of Bone Resorption in Osteoclasts K. Fuller, Brian Wong, Simon W. Fox, The Journal of Experimental Medicine	1998	569
Tumor necrosis factors <i>alpha</i> and <i>beta</i> induce osteoblastic cells to stimulate osteoclastic bone resorption. B.M. Thomson, G R Mundy, Tim Chambers The Journal of Immunology	1987	538
Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal Thomas J. Mitchell, Samra Turajlic, Andrew Rowan, Cell	2018	536
Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors Frederick Arce Vargas, Andrew J.S. Furness, Isabelle Solomon, Immunity	2017	425

Page 1